BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31930598)

  • 1. Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases.
    Butters A; Isbister JC; Medi C; Raju H; Turner C; Sy RW; Semsarian C; Ingles J
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):465-473. PubMed ID: 31930598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in patients with inherited cardiomyopathies.
    Yeung C; Enriquez A; Suarez-Fuster L; Baranchuk A
    Europace; 2019 Jan; 21(1):22-32. PubMed ID: 29684120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.
    Gunawardene MA; Dickow J; Schaeffer BN; Akbulak RÖ; Lemoine MD; Nührich JM; Jularic M; Sinning C; Eickholt C; Meyer C; Moser JM; Hoffmann BA; Willems S
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
    Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
    Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.
    Yoneda ZT; Anderson KC; Quintana JA; O'Neill MJ; Sims RA; Glazer AM; Shaffer CM; Crawford DM; Stricker T; Ye F; Wells Q; Stevenson LW; Michaud GF; Darbar D; Lubitz SA; Ellinor PT; Roden DM; Shoemaker MB
    JAMA Cardiol; 2021 Dec; 6(12):1371-1379. PubMed ID: 34495297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter.
    Almani MU; Talha KM; Khan LA; Hameed I; Asad ZUA; Fudim M; Krasuski R; Khan MS
    Am J Cardiol; 2024 Jul; 222():29-34. PubMed ID: 38636626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment.
    Cardona-Guarache R; Åström-Aneq M; Oesterle A; Asirvatham R; Svetlichnaya J; Marcus GM; Gerstenfeld EP; Klein L; Scheinman MM
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1801-1810. PubMed ID: 31310380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).
    Guttmann OP; Pavlou M; O'Mahony C; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Garcia-Pavia P; McKenna WJ; Omar RZ; Elliott PM;
    Eur J Heart Fail; 2015 Aug; 17(8):837-45. PubMed ID: 26183688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status of cardiac genetic disease patients and their at-risk relatives.
    Ingles J; Yeates L; Hunt L; McGaughran J; Scuffham PA; Atherton J; Semsarian C
    Int J Cardiol; 2013 May; 165(3):448-53. PubMed ID: 21930314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
    Choi YJ; Choi EK; Han KD; Jung JH; Park J; Lee E; Choe W; Lee SR; Cha MJ; Lim WH; Oh S
    Int J Cardiol; 2018 Dec; 273():130-135. PubMed ID: 30150122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.